Cargando…

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells

SARS-CoV-2 receptor-binding domain (RBD) is a major target for the development of diagnostics, vaccines and therapeutics directed against COVID-19. Important efforts have been dedicated to the rapid and efficient production of recombinant RBD proteins for clinical and diagnostic applications. One of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerez, Guillaume, Martinez, Jerome, Steinbrugger, Christophe, Bouanich, Sandra, Dimino, Johanna, Piegay, Corine, Combe, Maxime, Berthier, Franck, Daniel, Soizic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496381/ https://www.ncbi.nlm.nih.gov/pubmed/36139010 http://dx.doi.org/10.3390/biom12091170

Ejemplares similares

Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates
por: Mendoza-Ramírez, Noe Juvenal, et al.
Publicado: (2023)

Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications
por: García-Cordero, Julio, et al.
Publicado: (2021)

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
por: Leal, Lorna, et al.
Publicado: (2023)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
por: Lanza, Giuseppe, et al.
Publicado: (2022)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
por: Sinha, Siddharth, et al.
Publicado: (2021)

Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells
por: Gstöttner, Christoph, et al.
Publicado: (2021)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
por: Sun, Shihui, et al.
Publicado: (2021)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
por: Barreiro, Antonio, et al.
Publicado: (2023)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

A Recombinant RBD-Based Phage Vaccine Report: A Solution to the Prevention of New Diseases?
por: Salehi, Zahra, et al.
Publicado: (2023)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Neurologic and psychiatric features of impending neurodegeneration in iRBD
por: Barone, Daniel A., et al.
Publicado: (2023)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
por: Dormeshkin, Dmitri, et al.
Publicado: (2023)

Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

2356. Close correlation of RBD with Live Viral Neutralising Capacity Across Variants and Time Supports Use of RBD Thresholds to Predict Protective Host Immunity
por: Kenny, Grace, et al.
Publicado: (2023)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
por: Bertoglio, Federico, et al.
Publicado: (2021)

EOS deployment on Ceph RBD/CephFS with K8s
por: Fornari, Federico, et al.
Publicado: (2023)

REM sleep behavior disorder (RBD): Update on diagnosis and treatment
por: Högl, Birgit, et al.
Publicado: (2016)

Multi-modal Brain MRI in Subjects with PD and iRBD
por: Mangia, Silvia, et al.
Publicado: (2017)

Insomnia and somnolence in idiopathic RBD: a prospective cohort study
por: Postuma, Ronald B., et al.
Publicado: (2017)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Sodium oxybate—a new horizon for symptomatic treatment of RBD?
por: Stefani, Ambra, et al.
Publicado: (2023)

Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
por: Renard, Nathalie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bf3h5ugofkh77s2a8t4cgsn2u5